Merck Awarded Canadian CRISPR Nickase Patent for Foundational ...
DARMSTADT, Germany, March 5, 2019 /PRNewswire-AsiaNet/ -- -- Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects-- Marks company's 13th CRISPR patent overall-- Actively licensing CRISPR-related patents to interested partiesMerck ( https...
Authors: LATEST ASIANET NEWS RELEASES